Intra-Cellular Therapies Inc (ITCI) stock saw a decline, ending the day at $126.9 which represents a decrease of $-0.29 or -0.23% from the prior close of $127.19. The stock opened at $127.24 and ...
Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...